Generare secures €20M to scale molecular discovery platform
Tech.eu / 4/2/2026
📰 NewsIndustry & Market MovesModels & Research
Key Points
- Generare raised €20M to expand its molecular discovery platform that generates novel molecular data for drug discovery.
- The funding is aimed at scaling both the company’s research efforts and the size/coverage of its underlying dataset.
- The company’s approach supports the development of new compounds by producing synthetic molecular data to accelerate discovery workflows.
- The round signals continued investment momentum in computational/genAI-assisted biotech and molecular design tooling.
- As the platform scales, it may increase throughput for discovery teams and strengthen Generare’s position in molecular data generation and research services.
Generare,a Paris-based biotechnology company focused on generating molecular data fordrug development, has raised €20 million in a Series A funding round. The roundwas co-led by Alven and Daphni, with...
Continue reading this article on the original site.
Read original →Related Articles
Black Hat USA
AI Business
Black Hat Asia
AI Business
v5.5.0
Transformers（HuggingFace）Releases
Bonsai (PrismML's 1 bit version of Qwen3 8B 4B 1.7B) was not an aprils fools joke
Reddit r/LocalLLaMA
Big Tech firms are accelerating AI investments and integration, while regulators and companies focus on safety and responsible adoption.
Dev.to
